Aster MIMS Kozhikode and Qure.ai Partner To implement AI-powered Solution

India Pharma Outlook Team | Monday, 25 March 2024

 AI solutions, clinical imaging, India Pharma Outlook

In a huge step towards improving stroke care and determination, Aster MIMS Emergency Clinic in Kozhikode has joined hands with Qure.ai, a provider of AI solutions for clinical imaging. This cooperation presents a creative artificial intelligence-fueled Center Point and Spoke model pointed toward facilitating diagnosis and further developing consideration coordination for stroke-thought patients across its spoke destinations, the healthcare provider added.

The AI-enabled head CT solution Qure.ai's qER suite can process CT scans in less than three minutes, ensuring prompt assessment and diagnosis in suspected stroke cases. The Qure Application works with continuous correspondence of patient data and radiology pictures to multi-disciplinary groups at the center point site (Aster MIMS), streamlining interventions.

The Center Point and Spoke model interface asset provoked talked clinics to a focal center point emergency clinic, improving the medical services framework and encouraging consistent care coordination. As the hub hospital for this collaboration, Aster MIMS Calicut will connect with four spoke hospitals on the outskirts of Kozhikode. The organization expects to treat roughly 1500 stroke patients yearly, including 600 patients from the associated sites.

Dr Ashraj V, one of the senior consultants at Aster Institute of Neurosciences, pointed out the importance of timely stroke treatment worked with by the artificial intelligence-controlled Center and Talked model. He featured the Qure Application's part in successful cooperation across the network, improving medical care foundation usage. 

Dr Abdurehiman KP, the head of neurology at Aster MIMS Calicut, commended the organization of Qure.ai's answers, noticing the progressions in stroke care and analysis. He lauded the AI-enabled head CT answer for facilitating analysis and the care coordination application for lessening Turnaround Time (TAT) through continuous case warnings and cautions.

© 2024 India Pharma Outlook. All Rights Reserved.